DUTCH Weight Control in Atrial Fibrillation Study
DUTCH Weight Control in Atrial Fibrillation Study, a Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled Trial
Rijnstate Hospital
280 participants
Jul 21, 2024
INTERVENTIONAL
Conditions
Summary
Quantify the effect of an innovative weight loss management on rhythm control.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intervention arm receives semaglutide in addition to combined lifestyle intervention
Control arm receives placebo in addition to combined lifestyle intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06184633